tiprankstipranks
Dermata Therapeutics (DRMA)
NASDAQ:DRMA
US Market
DRMA
Dermata Therapeutics
RESEARCH TOOLSreports

Dermata Therapeutics (DRMA) Financial Statements

153 Followers

Dermata Therapeutics Financial Overview

Dermata Therapeutics's market cap is currently $4.91M. The company's EPS TTM is $-0.35; its P/E ratio is -0.28; Dermata Therapeutics is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -7.77M$ -12.51M$ -8.04M$ -9.67M$ -7.86M
EBITDA$ -7.77M$ -12.29M$ 247.22K$ -9.61M$ -7.86M
Net Income$ -7.56M$ -12.29M$ -7.79M$ -9.61M$ -7.90M
Balance Sheet
Cash & Short-Term Investments$ 7.52B$ 3.16M$ 7.44M$ 6.24M$ 10.80M
Total Assets$ 7.86B$ 3.53M$ 7.98M$ 6.94M$ 11.62M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -7.52B$ -3.16M$ -7.44M$ -6.24M$ -10.80M
Total Liabilities$ 1.64B$ 1.97M$ 1.62M$ 922.63K$ 1.52M
Stockholders' Equity$ 6.22B$ 1.56M$ 6.36M$ 6.02M$ 10.11M
Cash Flow
Free Cash Flow$ -7.76B$ -11.16M$ -6.41M$ -8.83M$ -5.69M
Operating Cash Flow$ -7.76B$ -11.16M$ -6.41M$ -8.83M$ -5.69M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 12.12B$ 6.89M$ 7.61M$ 4.28M$ 15.96M
Currency in USD

Dermata Therapeutics Earnings and Revenue History

Income Statement >

Dermata Therapeutics Debt to Assets

Balance Sheet >

Dermata Therapeutics Cash Flow

Cash Flow >

Dermata Therapeutics Forecast EPS vs Actual EPS

Earnings >